Author

Liang Qiao

The University of SydneyORCID 0000-0002-4723-8935Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Liang Qiao4 papers · Chinese Academy of Sciences

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

Ankur SharmaiD· 1 shared Bicheng Yang· 1 shared Brian GlossiD· 1 shared Catherine L. WorthiD· 1 shared Christopher LiddleiD· 1 shared Costerwell KhyriemiD· 1 shared Daniele VitaleiD· 1 shared Duncan J. McLeodiD· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Ankur SharmaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

STOmics-GenX: CRISPR based approach to improve cell identity specific gene detection from spatially resolved transcriptomics

Jennifer Currenti, Liang Qiao, Rhea Pai, Saurabh Gupta, Costerwell Khyriem, Kellie Wise, Xiaohuan Sun, Jon R. Armstrong, Jordan Crane, Smita Pathak, Bicheng Yang, Jacob George, Jasmine Plummer, Luciano Gastón Martelotto, Ankur Sharma

STOmics-GenX improves gene detection in spatial transcriptomics by integrating CRISPRclean with Stereo-seq, enhancing cell type annotation and biomarker identification in hepatocellular carcinoma.

bioRxiv · Dec 8, 2022 · PreprintMolecular Biology

Higher basal tumor immune activity coupled with a systemic immune response improves liver cancer outcomes

Ghazal Alipour Talesh, Daniele Vitale, Peter Langfelder, Mahmoud Karimi Azardaryany, Michael J. Berry, T. Grant Belgard, Jocelyn M. Choo, Geraint B. Rogers, Vikki Ho, Mehdi Ramezani–Moghadam, Suat Dervish, Joey Lai, Brian Gloss, Catherine L. Worth, Duncan J. McLeod, , Saeed Esmaili

The paper shows that stronger systemic and liver immune responses improve liver cancer outcomes by reducing tumor burden and correlating with better survival.

bioRxiv · Apr 16, 2022 · PreprintCancer Biology